TRMT5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.822400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.771800E-01
Normal-vs-Stage2
7.362600E-01
Normal-vs-Stage3
2.533000E-01
Normal-vs-Stage4
2.664200E-01
Stage1-vs-Stage2
4.259600E-01
Stage1-vs-Stage3
1.104370E-01
Stage1-vs-Stage4
3.755200E-01
Stage2-vs-Stage3
7.939900E-02
Stage2-vs-Stage4
2.883800E-01
Stage3-vs-Stage4
8.899800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.544600E-01
Normal-vs-AfricanAmerican
9.106600E-01
Normal-vs-Asian
5.812200E-01
Caucasian-vs-AfricanAmerican
6.421000E-01
Caucasian-vs-Asian
1.273960E-01
AfricanAmerican-vs-Asian
4.689000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.409200E-01
Normal-vs-Female
6.275600E-01
Male-vs-Female
3.658400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.964600E-01
Normal-vs-Age(41-60Yrs)
4.074200E-01
Normal-vs-Age(61-80Yrs)
8.619000E-01
Normal-vs-Age(81-100Yrs)
6.090600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.929600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.225400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.826600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.898500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.329200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.899400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.821000E-01
Normal-vs-Daily Drinker
9.750200E-01
Normal-vs-Weekly Drinker
8.117400E-01
Normal-vs-Occasional Drinker
2.077400E-01
Normal-vs-Social Drinker
3.995200E-01
Non Drinker-vs-Daily Drinker
9.843000E-01
Non Drinker-vs-Weekly Drinker
5.735400E-01
Non Drinker-vs-Occasional Drinker
8.484500E-03
Non Drinker-vs-Social Drinker
1.646250E-01
Daily Drinker-vs-Weekly Drinker
5.922600E-01
Daily Drinker-vs-Occasional Drinker
1.367930E-02
Daily Drinker-vs-Social Drinker
1.792030E-01
Weekly Drinker-vs-Occasional Drinker
1.416050E-01
Weekly Drinker-vs-Social Drinker
6.020200E-01
Occasional Drinker-vs-Social Drinker
2.064800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.072600E-01
Normal-vs-Grade 2
7.096600E-01
Normal-vs-Grade 3
6.261200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.775800E-01
Grade 1-vs-Grade 3
6.756400E-02
Grade 1-vs-Grade 4
4.072600E-01
Grade 2-vs-Grade 3
6.809800E-02
Grade 2-vs-Grade 4
7.096600E-01
Grade 3-vs-Grade 4
6.261200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.356400E-01
Normal-vs-NonDiabetic
6.477800E-01
Diabetic-vs-NonDiabetic
9.206200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.457000E-01
Normal-vs-NoPancreatitis
6.892200E-01
Pancreatitis-vs-NoPancreatitis
1.174370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.668600E-01
Normal-vs-N1
7.032200E-01
N0-vs-N1
8.240400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.122400E-01
Normal-vs-TP53-NonMutant
6.286200E-01
TP53-Mutant-vs-TP53-NonMutant
5.473500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
